Anti-Human CD38 FITC

Description: The HIT2 monoclonal antibody reacts with the human CD38 molecule, an approximately 45 kDa type II transmembrane protein. CD38 is expressed by thymocytes, peripheral B cells including plasma cells, activated T cells, and monocytes. CD38 is a counter-receptor for CD31 and has both cyclase and hydrolase enzymatic activity.

References:
McMichael, A.J., P.C.L. Beverly, et al. eds. (1987). Leucocyte Typing III: White Cell Differentiation Antigens. Oxford University Press. New York.
Joshua, D., A. Petersen, et al. (1996). "The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis." Br J Haematol 94(1): 76-81.
Horenstein, A. L., H. Stockinger, et al. (1998). "CD38 binding to human myeloid cells is mediated by mouse and human CD31." Biochem J 330(Pt 3): 1129-35.
Deaglio, S., M. Morra, et al. (1998). "Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member." J Immunol 160(1): 395-402.